| Faron Pharmaceuticals Share Price | |||
|---|---|---|---|
| Price | 46.00 | Open | 46.00 |
| Bid | 45.00 | High | 46.00 |
| Ask | 47.00 | Low | 45.50 |
| Change | -1.40 (-2.95%) | Close | 47.40 |
| Volume | 88,245 | ||
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 199.51m |
| Market Cap | £91.78m |
| PE Ratio | -2.389112 |
| EPS | -19.25401 |
| Year High | 240.00 |
|---|---|
| Year High Date | 27-Aug-2025 |
| Year Low | 38.70 |
| Year Low Date | 29-Apr-2026 |
| Dividend | 0.00 |
| Yield | 0.00% |
| # Trades | 15 |
|---|---|
| Vol. Sold | 27,289 |
| Sold Value | £12.01k |
| Vol. Bought | 55,797 |
| Bought Value | £25.97k |
| Market Size | 1,500 |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-26 | 16:29:42 | 47.00 | 6,000 | Buy* | 45.00 | 47.00 | 2,820 | O Ordinary |
| 05-Jun-26 | 16:14:24 | 47.00 | 24,000 | Buy* | 45.00 | 47.00 | 11.28k | O Ordinary |
| 05-Jun-26 | 16:14:00 | 46.00 | 159 | Unknown* | 45.00 | 47.00 | 73.14 | O Ordinary Trade was executed as an SI |
| 05-Jun-26 | 16:13:56 | 46.00 | 25,000 | Buy* | 45.00 | 46.00 | 11.50k | O Ordinary |
| 05-Jun-26 | 16:12:54 | 46.00 | 159 | Buy* | 45.00 | 46.00 | 73.14 | O Ordinary |
| 05-Jun-26 | 16:12:54 | 46.00 | 159 | Buy* | 45.00 | 46.00 | 73.14 | O Ordinary Trade was executed as an SI |
| 05-Jun-26 | 13:37:10 | 46.00 | 159 | Buy* | 45.00 | 46.00 | 73.14 | O Ordinary |
| 05-Jun-26 | 13:37:10 | 46.00 | 56 | Buy* | 45.00 | 46.00 | 25.76 | O Ordinary Trade was executed as an SI |
| 05-Jun-26 | 13:35:22 | 44.00 | 27,289 | Sell* | 45.00 | 47.00 | 12.01k | O Ordinary |
| 05-Jun-26 | 11:51:09 | 47.00 | 99 | Buy* | 45.00 | 47.00 | 46.53 | O Ordinary Trade was executed as an SI |
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 31-Mar-26 | 30-Mar-26 | Placing | Tuomo Pätsi held the position of Chairman at the time of this trade.Tuomo Pätsi | 0.50 | EUR | 400,002 | 453,267 |
| 25-Mar-26 | 24-Mar-26 | Placing | Markku Jalkanen held the position of Non-Executive Director at the time of this trade.Markku Jalkanen | 0.50 | EUR | 100,008 | 1,725,274 |
| 19-Mar-26 | 17-Mar-26 | Placing | Juho Jalkanen held the position of CEO at the time of this trade.Juho Jalkanen | 0.50 | EUR | 684 | 1,368 |
| 19-Mar-26 | 17-Mar-26 | Placing | Juho Jalkanen held the position of CEO at the time of this trade.Juho Jalkanen | 0.50 | EUR | 684 | 1,368 |
| 19-Mar-26 | 17-Mar-26 | Placing | Juho Jalkanen held the position of CEO at the time of this trade.Juho Jalkanen | 0.50 | EUR | 1,431 | 1,368 |
We offer a promising immunotherapy candidate with a new target to fight cancer.